- Home
- GSK vs JCI Comparison
GSK vs JCI Comparison
Compare GSK & JCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GSK | JCI |
|---|---|---|
| Founded | 1715 | 1885 |
| Country | United Kingdom | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.1B | 84.0B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | GSK | JCI |
|---|---|---|
| Price | $55.51 | $133.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | N/A | ★ $132.54 |
| AVG Volume (30 Days) | ★ 5.3M | 3.7M |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | ★ 3.22% | 1.21% |
| EPS Growth | N/A | ★ 99.60 |
| EPS | N/A | ★ 0.85 |
| Revenue | N/A | ★ $9,902,000,000.00 |
| Revenue This Year | $6.81 | $7.66 |
| Revenue Next Year | $4.74 | $6.44 |
| P/E Ratio | ★ $32.75 | $155.48 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $32.38 | $68.03 |
| 52 Week High | $61.70 | $146.49 |
Technical Indicators
Market Signals| Indicator | GSK | JCI |
|---|---|---|
| Relative Strength Index (RSI) | 45.67 | 45.58 |
| Support Level | $47.89 | $111.18 |
| Resistance Level | $60.37 | $146.49 |
| Average True Range (ATR) | 0.89 | 3.38 |
| MACD | -0.86 | -2.03 |
| Stochastic Oscillator | 18.94 | 17.13 |
Price Performance
Historical ComparisonAbout GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About JCI Johnson Controls International plc
Following Johnson Controls' divestiture of its residential and light commercial HVAC businesses to Bosch in 2025, nearly all of its revenue comes from commercial HVAC (60%) and fire and security products and services (40%). A 2016 merger joined Johnson Controls' HVAC and Tyco's fire and security businesses with the premise that there is synergy in offering a broader variety of automation products and solutions to commercial buildings. We estimate Johnson Controls' pro forma revenue mix will be one-third products, one-third installation, and one-third services.